Clinical TrialID 6094
Pilot Study of Physostigmine-Enhanced Opioid Analgesia
NCT01394445
Postoperative Pain
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final clinical_trial record.
- Clinical Trial Id
- 6094
- Evidence Id
- 6094
- Core Evidence Id
- 6094
- Source Clinical Trial Id
- 6076
- Herb2 Clinical Trial Id
- HBCT006076
- Nct Id
- NCT01394445
- Title
- Pilot Study of Physostigmine-Enhanced Opioid Analgesia
- Status
- Completed
- Phase
- Phase 3
- Study Result
- No
- Study Condition
- Postoperative Pain
- Study Type
- Interventional
- Study Design
- Allocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
- Intervention
- DRUG: Physostigmine|DRUG: Placebo
- Intervention Allocation
- Randomized
- Intervention Model
- Single_Group
- Intervention Mask
- Triple
- Intervention Purpose
- Treatment
- Gender
- All
- Age
- Adult, Older_Adult
- Enrollment
- 20
- Outcome Measure
- opioid consumption, 24 hours
- Sponsor Collaborator
- Medical University of Graz
- Funded By
- OTHER
- Location
- Hospital of the Medical University of Graz, Graz, Styria, 8036, Austria
- Other Id
- 21-510ex09/10|2010-021901-19
- Start Date
- 2011-06
- Primary Completion Date
- 2011-12
- Completion Date
- 2011-12
- First Posted
- 2011-07-14
- Results First Posted
- Last Update Posted
- 2012-02-22
- Study Document
- Study Url
- https://clinicaltrials.gov/study/NCT01394445
- Title Cn
- Title En
- Pilot Study of Physostigmine-Enhanced Opioid Analgesia
- Bilingual Status
- semi_complete